CXCL8 and head and neck squamous cell carcinoma: Finally, IL-8 and lactate show distinct signatures across different HNSCC TME subtypes identified by the model, indicating the potential to be considered essential biomarkers for therapy resistance (Table 1 provides a compact representation of the biomarkers and targets identified by the proposed model).